Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

about

RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.

P2860

Q38541950-F2532B56-0147-42C0-9974-4D548B629B28 Q52719561-8903F20A-7C63-43C4-AAF4-06B19A4E2B6F

P2860

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

Item

http://www.wikidata.org/entity/Q38925083

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

@en

type

Item

label

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

@en

prefLabel

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

@en

P1476

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

@en

P2093

Haitao Xu

http://www.w3.org/2001/XMLSchema#string

Liquan Wu

http://www.w3.org/2001/XMLSchema#string

Shulan Huang

http://www.w3.org/2001/XMLSchema#string

Wei Yi

http://www.w3.org/2001/XMLSchema#string

Xiaonan Zhu

http://www.w3.org/2001/XMLSchema#string

Xiaoqi Nie

http://www.w3.org/2001/XMLSchema#string

P2860

Computational models with thermodynamic and composition features improve siRNA design.

Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Resistance to chemotherapy in cancer: a complex and integrated cellular response.

Multiple drug resistance mechanisms in cancer.

Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.

Drug resistant breast cancer cells overexpress ETS1 gene.

Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.

The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.

Development and characterisation of chitosan nanoparticles for siRNA delivery.

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.

P2888

s12013-014-0442-2

P304

227-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12013-014-0442-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042350783

http://www.w3.org/2001/XMLSchema#string

P698

25543328

http://www.w3.org/2001/XMLSchema#string

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

about

P2860

P2860

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698